Clinical Trial Update: Evaluation of BRUDYGLAUCO (DHA + Citicoline) in Patients With Glaucoma [NA]

View source ↗

Summary

Clinical trial update indicates that BRUDYGLAUCO (DHA + citicoline) is currently recruiting to evaluate its effects in glaucoma, including primary open-angle gl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Open-angle Glaucoma

Drugs mentioned

• BRUDYGLAUCO (DHA + citicoline)

Snippet

Sponsor: Institut Catala de Retina | Conditions: Glaucoma, Primary Open Angle Glaucoma (POAG) | NA | Status: RECRUITING